Advances in Drug Formulation & Delivery Part II

Join us at this virtual conference to learn about new insights and advances in the area of drug formulation & delivery. Even the most promising API can have development challenges that require innovative solutions to reach its final drug product. Our virtual conference will address four of these areas with tracks on the following: Enhanced Bioavailability, Long acting injectable/implantable, and Formulation in the Clinic.

Upcoming Events

Feb 23rd, 2021

9:00am PDT

Dr. Sean McMahon,

Business and Technical Manager at Ashland
Extended Release Injectables: ViatelTM Bioresorbable Polymer Design for Success

March 2nd, 2021

9:00am PDT

Dr. Abu Serajuddin,

Professor of Industrial Pharmacy at St. John’s University
Title to be announced

FULL AGENDA

REGISTER NOW

Accelerated Development	Enhanced Bioavailability	Long Acting Delivery	Formulation in the Clinic
Approaches that enhance solubility of challenging API to enable clinically viable formulations	Discovery & preclinical approaches that enable rapid development	Topics covered will include uses of technologies such as: amorphous solid dispersion, continuous granulation, coating and extrusion	Innovative approaches to address oral delivery of biologics, including: proteins, peptides, nucleic acids, and beyond
Tim Smith, Freund-Vector Corporation(More Info) Bottom Spray (Wurster) Coating: Understanding the Challenges, Processing & Scale-Up Considerations – March 16th Charles Vesey, Colorcon, Inc (More Info) Formulation Strategies and Tools for Accelerated Development of Solid Oral Dosage Forms – March 9th Dr. Changquan Calvin Sun, University of Minnesota (UMN) (More Info) Material-sparing and expedited development of tablets for early clinical testing – April 13th Wenzhan Yang, AstraZeneca (More Info) Small Molecule Drug Delivery Approaches to Modulate Target Engagement in Drug Discovery – TBD	Dr. Abu Serajuddin, St. John’s University University(More Info) Title to be announced – March 2nd, 2021 Dr. Dave A. Miller, DisperSol Technologies (More Info) The Importance of Particle Properties on the Biopharmaceutical Performance of Amorphous Solid Dispersions – March 30th, 2021 Dr. Dana E. Moseson, Purdue University (More Info) Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions – May 11th, 2021	Dr. Ketan Patel, St. John’s University (More Info) Development of self-medicated formulations of Remdesivir for COVID-19: Extended release in-situ depot and pulmonary liposome – April 6th Dr. Sean McMahon, Ashland (More Info) Extended Release Injectables: ViatelTM Bioresorbable Polymer Design for Success – Feb 23rd, 2021 Dr. Tom Tice, Evonik Corporation (More Info) Lactide/Glycolide Parenteral Excipients for Successful Drug Delivery Solution – March 23rd, 2021 Dr. Mark A. Tracy, Tracy BioConsulting, LLC. (More Info) Lessons Learned in Advancing Sustained Release Polymer Microparticle Products into the Clinic – May 4th, 2021 Dr. Jeffrey Leyton, Université de Sherbrooke (More Info) Journey to the Center of the Cell: Reprogramming Intracellular Transport to the Nucleus Enhances Tumor Killing for Antibodies Conjugated to Nuclear-Active Payloads – TBD	Dr. Larry Ereshefsky, Hassman Research Institute and CNS Research(More Info) Optimizing Formulations in Early Phase Development: The view from the ‘clinical’ side – TBD

Accelerated Development

Enhanced Bioavailability

Long Acting Delivery

Formulation in the Clinic

Approaches that enhance solubility of challenging API to enable clinically viable formulations

Discovery & preclinical approaches that enable rapid development

Topics covered will include uses of technologies such as: amorphous solid dispersion, continuous granulation, coating and extrusion

Innovative approaches to address oral delivery of biologics, including: proteins, peptides, nucleic acids, and beyond

Tim Smith, Freund-Vector Corporation(More Info)
Bottom Spray (Wurster) Coating: Understanding the Challenges, Processing & Scale-Up Considerations – March 16th

Charles Vesey, Colorcon, Inc (More Info)
Formulation Strategies and Tools for Accelerated Development of Solid Oral Dosage Forms
– March 9th

Dr. Changquan Calvin Sun, University of Minnesota (UMN) (More Info)
Material-sparing and expedited development of tablets for early clinical testing
– April 13th

Wenzhan Yang, AstraZeneca (More Info)
Small Molecule Drug Delivery Approaches to Modulate Target Engagement in Drug Discovery
– TBD

Dr. Abu Serajuddin, St. John’s University University(More Info)
Title to be announced – March 2nd, 2021

Dr. Dave A. Miller, DisperSol Technologies
(More Info)
The Importance of Particle Properties on the Biopharmaceutical Performance of Amorphous Solid Dispersions – March 30th, 2021

Dr. Dana E. Moseson, Purdue University
(More Info)
Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions – May 11th, 2021

Dr. Ketan Patel, St. John’s University (More Info)
Development of self-medicated formulations of Remdesivir for COVID-19: Extended release in-situ depot and pulmonary liposome – April 6th

Dr. Sean McMahon, Ashland (More Info)
Extended Release Injectables: ViatelTM Bioresorbable Polymer Design for Success – Feb 23rd, 2021

Dr. Tom Tice, Evonik Corporation (More Info)
Lactide/Glycolide Parenteral Excipients for Successful Drug Delivery Solution – March 23rd, 2021

Dr. Mark A. Tracy, Tracy BioConsulting, LLC. (More Info)
Lessons Learned in Advancing Sustained Release Polymer Microparticle Products into the Clinic – May 4th, 2021

Dr. Jeffrey Leyton, Université de Sherbrooke (More Info)
Journey to the Center of the Cell: Reprogramming Intracellular Transport to the Nucleus Enhances Tumor Killing for Antibodies Conjugated to Nuclear-Active Payloads – TBD

Dr. Larry Ereshefsky, Hassman Research Institute and CNS Research(More Info)
Optimizing Formulations in Early Phase Development: The view from the ‘clinical’ side – TBD

Accelerated Development: Fast path to the clinic	Discovery & preclinical approaches that enable rapid development	Dr. Daniel Treffer, Melt Prep (More Info) Rapid and lossless prototyping of HME formulations in the milligram to gram scale via Vacuum Compression Molding – June 30th View recording Q&A Dr. Chad Brown, Merck (More Info) Hot Melt Extrusion as a Key Enabler of Developing Products of Low Solubility Compounds – June 2nd Q&A Dr. Xiaohu Deng, Viracta (More Info) Phase-appropriate CMC Strategies in Drug Product Development – July 14th View recording Q&A Chandra Kelley, Pfanstiehl (More Info) Key Considerations in Accelerating Biopharma Formulation Development – August 11th Seth Forster, Merck (More Info) Long-Acting Implants: Design for Durable Drug Delivery – August 4th Dr. John Shelley, Schrodinger (More Info) Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling – July 28th View recording Dr. Andrea Browning, Schrodinger (More Info) Formulation Development for Small Molecules and Biologics Enhancements with Molecular Modeling – July 28th View recording Dr. Raimar Löbenberg, University of Alberta (More Info) Presentation title coming soon – Date TBD
Enhanced Bioavailability	Approaches that enhance solubility of challenging API to enable clinically viable formulations	Dr. Harsh Chauhan, Creighton University (More Info) Formulation Considerations for development of Ternary Solid Dispersions – June 23rd View recording Dr. Dedong Wu, Astrazeneca (More Info) Improving Bioavailability by Prodrug Approach – September 1st Dr. Feng Zhang, UT Austin (More Info) Hot-melt extrusion to prepare amorphous solid dispersions: key concepts and common misperceptions – July 7th View recording Q&A Dr. Mo Maniruzzaman, UT Austin (More Info) 3D printing and state-of-the-art manufacturing techniques to advance drug delivery – Date TBD Dr. Yi-Ling Hsieh, AbbVie (More Info) Lipid-Based Formulation – The Impact on Biopharmaceutics and Patient Centricity – July 21st View recording Dr. Abu Serajuddin, St. John’s University (More Info) Development of HPMCAS-based amorphous solid dispersions by melt extrusion 21st – Date TBD
Continuous Processing	Topics covered will include uses of technologies such as: amorphous solid dispersion, continuous granulation, coating and extrusion	Dr. Michael Thompson, McMaster University (More Info) Developments in Twin-Screw Granulation – May 26th View recording Q&A Andy Birkmire, GEA (More Info) Successful Strategies for Developing a Continuous Manufacturing Process – June 9thView recording Q&A Jim Marjeram, O’Hara (More Info) Advantages of Continuous Tablet Coating – September 8th
Oral Delivery	Innovative approaches to address oral delivery of biologics, including: proteins, peptides, nucleic acids, and beyond	Dr. John Vrettos, Enteris BioPharma (More Info) Breaking Through the Barriers of Oral Biologics – June 16thView recording Q&A Dr. Stephen Hoag, University of Maryland (More Info) Presentation title coming soon – Date TBD

REGISTER NOW